Pulmonx Corporation (LUNG) Tops Q2 EPS by 4c

Pulmonx Corporation (NASDAQ: LUNG) reported Q2 EPS of ($0.24), $0.04 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $22.8 million versus the consensus estimate of $22.41 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.

You May Also Be Interested In

• Top Wealth Group expects net profit to double in fiscal 2026
• McDonald's sets 2030 financial targets with new growth strategy
• Annovis Bio partners with Weave Bio on AI platform for NDA filing